Real world use of long-acting cabotegravir and rilpivirine in a HIV centre in Hong Kong

被引：0
|
作者：
Chan, M. C. J. [1 ]
Chik, S. H. T. [1 ]
Lamb, S. S. [1 ]
Choi, Y. C. C. [1 ]
Lau, W. T. A. [1 ]
Leung, C. S. E. [1 ]
To, P. Y. L. [1 ]
Lau, P. L. D. [1 ]
Tsang, T. Y. O. [1 ]
机构：
[1] Hosp Author Infect Dis Ctr, Hong Kong, Peoples R China
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
814
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [1] Use of long-acting injectable cabotegravir/rilpivirine in people with HIV and adherence challenges
    Christopoulos, Katerina A.
    Hickey, Matthew D.
    Rana, Aadia
    CURRENT OPINION IN HIV AND AIDS, 2025, 20 (01) : 11 - 18
  • [2] Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV
    van der Wekken-Pas, Lena
    Weiss, Fabian
    Simon-Zuber, Charlotte
    Sebisch, Rena
    Wiese, Carmen
    van Leeuwen, Elisabeth
    Burger, David
    Colbers, Angela
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1468 - 1471
  • [3] Effectiveness and timing of viral load measurement in real-world use of long-acting cabotegravir-rilpivirine in people with HIV
    Fernandez-Hinojal, F.
    de Gea Grela, A.
    Martin-Carbonero, L.
    Valencia, E.
    Mican, R.
    Busca, C.
    Ramos, L.
    Arribas, J. R.
    Gonzalez-Garcia, J.
    Bernardino, J. I.
    Montes, M. L.
    HIV MEDICINE, 2023, 24 : 119 - 120
  • [4] Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Michael G. Sension
    Laurence Brunet
    Ricky K. Hsu
    Jennifer S. Fusco
    Quateka Cochran
    Christine Uranaka
    Gayathri Sridhar
    Vani Vannappagari
    Jean Van Wyk
    Lewis McCurdy
    Michael B. Wohlfeiler
    Gregory P. Fusco
    Infectious Diseases and Therapy, 2023, 12 : 2807 - 2817
  • [5] Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation
    Wood, Brian R.
    Kassaye, Seble G.
    Gerstoft, Jan
    AIDS, 2023, 37 (04) : 689 - 691
  • [6] Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
    Swindells, Susan
    Andrade-Villanueva, Jaime-Federico
    Richmond, Gary J.
    Rizzardini, Giuliano
    Baumgarten, Axel
    Masia, Mar
    Latiff, Gulam
    Pokrovsky, Vadim
    Bredeek, Fritz
    Smith, Graham
    Cahn, Pedro
    Kim, Yeon-Sook
    Ford, Susan L.
    Talarico, Christine L.
    Patel, Parul
    Chounta, Vasiliki
    Crauwels, Herta
    Parys, Wim
    Vanveggel, Simon
    Mrus, Joseph
    Huang, Jenny
    Harrington, Conn M.
    Hudson, Krischan J.
    Margolis, David A.
    Smith, Kimberly Y.
    Williams, Peter E.
    Spreen, William R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1112 - 1123
  • [7] Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV
    Taramasso, Lucia
    Bonora, Stefano
    Cingolani, Antonella
    Di Biagio, Antonio
    Gianotti, Nicola
    Guaraldi, Giovanni
    Lo Caputo, Sergio
    Madeddu, Giordano
    Maggi, Paolo
    Marchetti, Giulia
    Nozza, Silvia
    Rusconi, Stefano
    Maggiolo, Franco
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025, 80 (03) : 610 - 623
  • [8] Cabotegravir plus Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Sension, Michael G.
    Brunet, Laurence
    Hsu, Ricky K.
    Fusco, Jennifer S.
    Cochran, Quateka
    Uranaka, Christine
    Sridhar, Gayathri
    Vannappagari, Vani
    Van Wyk, Jean
    Mccurdy, Lewis
    Wohlfeiler, Michael B.
    Fusco, Gregory P.
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (12) : 2709 - 2724
  • [9] Long-acting cabotegravir and rilpivirine in HIV individuals with a BMI over 30: a real-world study (RELATIVITY cohort)
    Troya, Jesus
    Morano, Luis
    Ignacio Bernardino, Jose
    Buzon Martin, Luis
    Pedrero Tome, Roberto
    Galindo Puerto, Maria Jose
    Torralba, Miguel
    Cabello Clotet, Noemi
    Garcia Lopez, Maria
    Lope, Silvia
    de Zarraga Fernandez, Miguel Alberto
    Cabello, Alfonso
    Aguilera Garcia, Maria
    Cecilio, Alvaro
    Diaz de Santiago, Alberto
    Garcinuno Jimenez, Maria Angeles
    Bernal, Enrique
    Lopez Caballero, Maria Teresa
    Calderon Hernaiz, Ruth
    Vivancos Gallego, Maria Jesus
    Omiste Sanvicente, Teresa
    Ferreira Pasos, Eva
    Losa Garcia, Juan Emilio
    Soler Gonzalez, Josefa Francisca
    Antonia Sepulveda, Maria
    Garcia Navarro, Maria del Mar
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 92 - 93
  • [10] Implementing long-acting injectable cabotegravir and rilpivirine in Africa
    Orkin, Chloe
    Ring, Kyle
    LANCET INFECTIOUS DISEASES, 2024, 24 (10): : 1060 - 1061
12345